KRKA, d.d., Novo mesto (manufacturing of finished medicinal product, primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo mesto (primary and secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used to treat ulcerative colitis and Crohn's disease (to achieve and maintain remission), as well as to treat rheumatoid arthritis in adults and juvenile rheumatoid arthritis in children.
Dosage form: tablets, film-coated
Active substance Dosage sulfasalazine 500 mg ATC: A07EC01
-
The drug is used for the treatment of ulcerative colitis (mild to moderate and as an adjunct in severe cases), as well as for the treatment of rheumatoid arthritis and juvenile rheumatoid arthritis in cases where other anti-inflammatory agents have not been effective.
Dosage form: tablets, enteric-coated
Active substance Dosage sulfasalazine 500 mg ATC: A07EC01